Nonoperating Income (Expense) of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TC BioPharm (Holdings) plc annual and quarterly Nonoperating Income (Expense) in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Nonoperating Income (Expense) for the quarter ending 31 Mar 2024 was £9,060, a 100% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2024 was £38,331, a 101% decline from 2023.
  • TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2023 was £7,243,641, a 20% decline from 2022.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Annual (GBP)
Nonoperating Income (Expense), YoY Annual Change (%)
Nonoperating Income (Expense), Quarterly (GBP)
Nonoperating Income (Expense), YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Nonoperating Income (Expense) (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £38,331 -£7,281,972 -101% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £7,243,641 -£1,806,755 -20% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £9,050,396 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Nonoperating Income (Expense) (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £9,060 -£3,121,794 -100% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £3,130,854 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.